FlexWave Trial: Efficacy of Extracorporeal Shock Wave Therapy in Post-Stroke Upper Limb Spasticity
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNational Taiwan University Hospital
About this trial
Extracorporeal shock wave therapy (ESWT) has emerged as an effective therapeutic intervention for addressing post-stroke limb spasticity. This research aims to explore the therapeutic implications of focused ESWT for wrist and finger flexor muscles in patients suffering from post-stroke upper limb spasticity.
Eligibility criteria
Qualifiers
Individuals aged 18 years or older with unilateral cerebral stroke.
Wrist and finger flexor muscle tone with a score greater than 1 on the Modified Ashworth Scale.
Stable medical condition and vital signs.
Conscious and able to comply with instructions.
Disqualifiers
History of more than one stroke, traumatic brain injury, or cerebral neoplasm.
Coexisting central nervous system disorders (e.g., spinal cord injury, Parkinson's disease) or other musculoskeletal diseases affecting muscle tone assessment.
Contraindications for shockwave intervention, such as malignancies, coagulopathies, local infections, or use of cardiac pacemakers.
Undergone shockwave therapy or botulinum toxin injections for post-stroke spasticity in the past three months.
Trial design
Treatments tested in this trial
- focused extracorporeal shock wave therapy (ESWT)
Treatment groups
40 Participants
are divided into 2 treatment groupsLocations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Department of Physical Medicine & Rehabilitation , National Taiwan University HospitalRecruiting100, Taipei, Taipei
Taiwan
TaiwanSponsors and collaborators
Source ClinicalTrials.gov